![]() |
Volumn 33, Issue 7, 2015, Pages 733-735
|
Reducing hydrophobicity of homogeneous antibody-drug conjugates improves pharmacokinetics and therapeutic index
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HYDROPHOBICITY;
ANTIBODY-DRUG CONJUGATES;
IN-VITRO;
IN-VIVO;
PEGYLATED;
PLASMA CLEARANCES;
THERAPEUTIC INDEX;
ANTIBODIES;
ANTIBODY CONJUGATE;
ANTIBODY DRUG CONJUGATE;
UNCLASSIFIED DRUG;
VEDOTIN;
DRUG;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CONTROLLED STUDY;
DRUG CLEARANCE;
DRUG CONJUGATION;
DRUG DESIGN;
DRUG FORMULATION;
DRUG POTENCY;
FEMALE;
HUMAN;
HUMAN CELL;
HYDROPHOBICITY;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
RAT;
THERAPEUTIC INDEX;
ANIMAL;
CELL LINE;
CHEMICAL MODEL;
CHEMICAL PHENOMENA;
CHEMICAL STRUCTURE;
CHEMISTRY;
MEDICINAL CHEMISTRY;
SCID MOUSE;
ANIMALS;
CELL LINE;
CHEMISTRY, PHARMACEUTICAL;
HUMANS;
HYDROPHOBIC AND HYDROPHILIC INTERACTIONS;
IMMUNOCONJUGATES;
MICE;
MICE, SCID;
MODELS, CHEMICAL;
MODELS, MOLECULAR;
PHARMACEUTICAL PREPARATIONS;
|
EID: 84944441047
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt.3212 Document Type: Article |
Times cited : (377)
|
References (17)
|